3′,4′-Dihydroxyflavonol prevents diabetes-induced endothelial dysfunction in rat aorta

Life Sciences

Volumn 85, Issue 1-2, 2009, Pages 54-59

  Woodman, Owen L ^a,b   Malakul, Wachirawadee ^b,c  

^a RMIT UNIVERSITY   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c NARESUAN UNIVERSITY   (Thailand)

Author keywords

Diabetes; Endothelium; Flavonol; Relaxation; Superoxide

Indexed keywords

3',4' DIHYDROXYFLAVONOL; ACETYLCHOLINE; ANTIOXIDANT; CITRIC ACID; FLAVONOL DERIVATIVE; GLUCOSE; LUCIGENIN; NITROPRUSSIDE SODIUM; STREPTOZOCIN; SUPEROXIDE; UNCLASSIFIED DRUG; 10,10' DIMETHYL 9,9' BIACRIDINIUM; 10,10'-DIMETHYL-9,9'-BIACRIDINIUM; 3',4'-DIHYDROXYFLAVONOL; ACRIDINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; AORTA; ARTICLE; BATH; BLOOD VESSEL REACTIVITY; CHEMOLUMINESCENCE; CONTROL GROUP; CONTROLLED STUDY; DRY WEIGHT; ENDOTHELIAL DYSFUNCTION; GLUCOSE BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; MALE; NONHUMAN; OXIDATIVE STRESS; RAT; SPRAGUE DAWLEY RAT; TREATMENT DURATION; VASCULAR RING; ANIMAL; BODY WEIGHT; DIABETIC ANGIOPATHY; DRUG EFFECT; EXPERIMENTAL DIABETES MELLITUS; IN VITRO STUDY; LUMINESCENCE; METABOLISM; MUSCLE RELAXATION; PATHOLOGY; THORACIC AORTA; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE;

RATTUS;

ACRIDINES; ANIMALS; AORTA, THORACIC; BLOOD GLUCOSE; BODY WEIGHT; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC ANGIOPATHIES; ENDOTHELIUM, VASCULAR; FLAVONOLS; LUMINESCENCE; MALE; MUSCLE RELAXATION; MUSCLE, SMOOTH, VASCULAR; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; SUPEROXIDES;

EID: 67349163186     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2009.04.012     Document Type: Article

References (38)

1. Ajay M., Achike F.I., Mustafa A.M., and Mustafa M.R. Effect of quercetin on altered vascular reactivity in aortas isolated from streptozotocin-induced diabetic rats. Diabetes Research and Clinical Practice 73 1 (2006) 1-7
2. Anjaneyulu M., and Chopra K. Quercetin, an anti-oxidant bioflavonoid, attenuates diabetic nephropathy in rats. Clinical and Experimental Pharmacology and Physiology 31 4 (2004) 244-248
3. Chan E.C.H., Pannangpetch P., and Woodman O.L. Relaxation to flavones and flavonols in rat isolated thoracic aorta: mechanism of action and structure activity relationships. Journal of Cardiovascular Pharmacology 35 (2000) 326-333
4. Chan E.C.H., Drummond G.R., and Woodman O.L. 3′, 4′-dihydroxyflavonol enhances nitric oxide bioavailability and improves vascular function after ischemia and reperfusion injury in the rat. Journal of Cardiovascular Pharmacology 42 (2003) 727-735
5. Coskun O., Kanter M., Korkmaz A., and Oter S. Quercetin, a flavonoid antioxidant, prevents and protects streptozotocin-induced oxidative stress and β-cell damage in rat pancreas. Pharmacological Research 51 2 (2005) 117-123
6. Cotelle N. Role of flavonoids in oxidative stress. Current Topics in Medicinal Chemistry 1 6 (2001) 569-590
7. Crespo I., García-Mediavilla M.V., Almar M., González P., Tuñón M.J., Sánchez-Campos S., and González-Gallego J. Differential effects of dietary flavonoids on reactive oxygen and nitrogen species generation and changes in antioxidant enzyme expression induced by proinflammatory cytokines in Chang liver cells. Food and Chemical Toxicology 46 5 (2008) 1555-1569
8. Dai F.X., Diederich A., Skopec J., and Diederich D. Diabetes-induced endothelial dysfunction in streptozotocin-treated rats: role of prostaglandin endoperoxides and free radicals. Journal of the American Society of Nephrology 4 6 (1993) 1327-1336
9. De Vriese A.S., Verbeuren T.J., Van de Voorde J., Lameire N.H., and Vanhoutte P.M. Endothelial dysfunction in diabetes. British Journal of Pharmacology 130 5 (2000) 963-974
10. Diederich D., Skopec J., Diederich A., and Dai F.X. Endothelial dysfunction in mesenteric resistance arteries of diabetic rats: role of free radicals. American Journal of Physiology 266 3 Pt 2 (1994) H1153-1161
11. Engler M.B., and Engler M.M. The emerging role of flavonoid-rich cocoa and chocolate in cardiovascular health and disease. Nutrition Reviews 64 3 (2006) 109-118
12. Erlund I., Kosonen T., Alfthan G., Maenpaa J., Perttunen K., Kenraali J., Parantainen J., and Aro A. Pharmacokinetics of quercetin from quercetin aglycone and rutin in healthy volunteers. European Journal of Clinical Pharmacology 56 8 (2000) 545-553
13. Forbes J.M., Coughlan M.T., and Cooper M.E. Oxidative stress as a major culprit in kidney disease in diabetes. Diabetes 57 6 (2008) 1446-1454
14. Geleijnse J.M., Launer L.J., Van der Kuip D.A., Hofman A., and Witteman J.C. Inverse association of tea and flavonoid intakes with incident myocardial infarction: the Rotterdam study. The American Journal of Clinical Nutrition 75 5 (2002) 880-886
15. Grundy S.M., Benjamin I.J., Burke G.L., Chait A., Eckel R.H., Howard B.V., Mitch W., Smith Jr. S.C., and Sowers J.R. Diabetes and cardiovascular disease: a statement for healthcare professionals from the American heart association. Circulation 100 10 (1999) 1134-1146
16. Hattori Y., Kawasaki H., Abe K., and Kanno M. Superoxide dismutase recovers altered endothelium-dependent relaxation in diabetic rat aorta. American Journal of Physiology 261 4 Pt 2 (1991) H1086-1094
17. Hertog M.G.L., Kromhout D., Aravanis C., Blackburn H., Buzina R., Fidanza F., Pekkarinen M., Simic B.S., Toshima H., Feskens E.J.M., Hollman P.C.H., and Katan M.J. Flavonoid intake and long-term risk of coronary heart disease and cancer in the seven countries study. Archives of Internal Medicine 155 (1995) 381-386
18. Jiang F., Guo N., and Dusting G.J. Modulation of nicotinamide adenine dinucleotide phosphate oxidase expression and function by 3′,4′-dihydroxyflavonol in phagocytic and vascular cells. The Journal of Pharmacology and Experimental Therapeutics 324 1 (2008) 261-269
19. Kamata K., and Kobayashi T. Changes in superoxide dismutase mRNA expression by streptozotocin-induced diabetes. British Journal of Pharmacology 119 3 (1996) 583-589
20. Machha A., Achike F.I., Mustafa A.M., and Mustafa M.R. Quercetin, a flavonoid antioxidant, modulates endothelium-derived nitric oxide bioavailability in diabetic rat aortas. Nitric Oxide 16 4 (2007) 4042-4447
21. Malakul W., Thirawarapan S., Suvitayavat W., and Woodman O.L. Type 1 diabetes and hypercholesterolaemia reveal the contribution of endothelium-derived hyperpolarizing factor to endothelium-dependent relaxation of the rat aorta. Clinical and Experimental Pharmacology and Physiology 35 2 (2008) 192-200
22. Mayhan W.G., and Patel K.P. Treatment with dimethylthiourea prevents impaired dilatation of the basilar artery during diabetes mellitus. American Journal of Physiology 274 6 Pt 2 (1998) H1895-1901
23. Mehta J.L., Rasouli N., Sinha A.K., and Molavi B. Oxidative stress in diabetes: a mechanistic overview of its effects on atherogenesis and myocardial dysfunction. International Journal of Biochemistry and Cell Biology 38 5-6 (2006) 794-803
24. Middleton E., Kandaswami C., and Theoharides T.C. The effect of plant flavonoids on mammalian cells: implications for inflammation, heart disease and cancer. Pharmacological Reviews 52 (2000) 673-751
25. Pieper G.M., Langenstroer P., and Siebeneich W. Diabetic-induced endothelial dysfunction in rat aorta: role of hydroxyl radicals. Cardiovascular Research 34 1 (1997) 145-156
26. Pietta P.G. Flavonoids as antioxidants. Journal of Natural Products 63 7 (2000) 1035-1042
27. Ritchie R.H., Quinn J.M., Cao A.H., Drummond G.R., Kaye D.M., Favaloro J.M., Proietto J., and Delbridge L.M.D. The antioxidant tempol inhibits cardiac hypertrophy in the insulin-resistant glut4-deficient mouse in vivo. Journal of Molecular and Cellular Cardiology 42 6 (2007) 1119-1128
28. Romero M., Jimenez R., Sanchez M., Lopez-Sepulveda R., Zarzuelo M.J., O Valle F., Zarzuelo A., Perez-Vizcaino F., and Duarte J. Quercetin inhibits vascular superoxide production induced by endothelin-1: role of nadph oxidase, uncoupled enos and pkc. Atherosclerosis 202 1 (2008) 58-67
29. Salvemini D., Riley D.P., and Cuzzocrea S. SOD mimetics are coming of age. Nature Reviews Drug Discovery 1 (2002) 367-374
30. Sanchez M., Galisteo M., Vera R., Villar I.C., Zarzuelo A., Tamargo J., Perez-Vizcaino F., and Duarte J. Quercetin downregulates NADPH oxidase, increases enos activity and prevents endothelial dysfunction in spontaneously hypertensive rats. Journal of Hypertension 24 1 (2006) 75-84
31. Vessal M., Hemmati M., and Vasei M. Antidiabetic effects of quercetin in streptozotocin-induced diabetic rats. Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology 135 3 (2003) 357-364
32. Wang S., Dusting G.J., May C.N., and Woodman O.L. 3′,4′-dihydroxyflavonol reduces infarct size and injury associated with myocardial ischaemia and reperfusion in sheep. British Journal of Pharmacology 142 3 (2004) 443-452
33. Willcox B.J., Curb J.D., and Rodriguez B.L. Antioxidants in cardiovascular health and disease: key lessons from epidemiologic studies. The American Journal of Cardiology 101 10A (2008) 75D-86D
34. Woodman O.L., and Chan E. Vascular and anti-oxidant actions of flavonols and flavones. Clinical and Experimental Pharmacology and Physiology 31 11 (2004) 786-790
35. Woodman O.L., Meeker W.F., and Boujaoude M. Vasorelaxant and antioxidant activity of flavonols and flavones: structure-activity relationships. Journal of Cardiovascular Pharmacology 46 3 (2005) 302-309
36. Woodman O.L., Malakul W., Cao A.H., Xu Q., and Ritchie R.H. Atrial natriuretic peptide prevents diabetes-induced endothelial dysfunction. Life Sciences 82 15-16 (2008) 847-854
37. Zanetti M., Sato J., Katusic Z.S., and O Brien T. Gene transfer of superoxide dismutase isoforms reverses endothelial dysfunction in diabetic rabbit aorta. American Journal of Physiology 280 6 (2001) H2516-2523
38. Zou M.H., Cohen R., and Ullrich V. Peroxynitrite and vascular endothelial dysfunction in diabetes mellitus. Endothelium 11 2 (2004) 89-97